Cargando…
Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
The activating receptor NKG2D, expressed on different innate and adaptive cytotoxic lymphocytes, has been demonstrated to play an important role in anti-tumor immunity. Now evidence is provided that tumor suppressors control expression of its ligand ULBP2 supporting the role of this receptor-ligand...
Autores principales: | Heinemann, Anja, Paschen, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382901/ https://www.ncbi.nlm.nih.gov/pubmed/22754777 |
Ejemplares similares
-
NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013) -
The NKG2D ligand ULBP4 is not expressed by human monocytes
por: Lazarova, Mariya, et al.
Publicado: (2021) -
Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells
por: Schilling, Bastian, et al.
Publicado: (2013) -
STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
por: Le Bert, Nina, et al.
Publicado: (2014) -
Tumor suppressor ARF: The new player of innate immunity
por: Través, Paqui G., et al.
Publicado: (2012)